Safety profile of intravitreal triamcinolone acetonide

Journal of Ocular Pharmacology and Therapeutics

Volumn 23, Issue 3, 2007, Pages 304-310

  Baath, J ^a   Ells, A L ^b,c   Crichton, A ^a   Kherani, A ^b   Williams, R G ^b   Ells, Dana ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c Calgary Retina Consultants   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GATIFLOXACIN; OFLOXACIN; TRIAMCINOLONE ACETONIDE;

AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CENTRAL RETINA ARTERY OCCLUSION; COMORBIDITY; DIABETIC MACULAR EDEMA; DRUG SAFETY; ENDOPHTHALMITIS; FEMALE; FOLLOW UP; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; HYPOPYON; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARACENTESIS; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA CYSTOID EDEMA; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT OUTCOME; UVEITIS; VITREOUS HEMORRHAGE;

AGED; AGED, 80 AND OVER; ANTERIOR CHAMBER; ENDOPHTHALMITIS; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MIDDLE AGED; OPTIC NERVE DISEASES; PARACENTESIS; RETINAL ARTERY OCCLUSION; RETROSPECTIVE STUDIES; RISK FACTORS; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 34250798455     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.125     Document Type: Article

References (26)

1. Jonas, J.B., Kreissig, I., Sofker, A., et al. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch. Ophthalmol. 121(1):57-61, 2003.
2. Negi, A.K., Vernon, S.A., Lim, C.S., et al. Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular edema refractory to laser photocoagulation. Eye 19(7):747-751, 2005.
3. Ciardella, A.P., Klancnik, J., Schiff, W., et al. Intravitreal traimcinolone for the treatment of refractory diabetic macular edema with hard exudates: An optical coherence tomography study. Br. J. Ophthalmol. 88(9): 1131-1136, 2004.
4. Danis, R.P., Ciulla, T.A., Pratt, L.M., et al. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20(3):244-250, 2000.
5. Jonas, J.B., Kreissig, I., Hugger, P., et al. Intravitreal triamcinolone acetonide for exudative age-related macular degeneration. Br. J. Ophthalmol. 87(4):462-468, 2003.
6. Rechtman, E., Danis, R.P., Pratt, L.M., et al. Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration. Br. J. Ophthalmol. 88(3):344-347, 2004.
7. Ip, M.S., Gottlieb, J.S., Kahana, A., et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch. Ophthalmol. 122:1131-1136, 2004.
8. Ozkiris, A., Evereklioglu, C, Erkilic, K., et al. The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion. Eur. J. Ophthalmol. 15(1):96-101, 2005.
9. Antcliff, R.J., Spalton, D.J., Stanford, M.R., et al. Intravitreal triamcinolone for uveitic cystoid macular edema: An optical coherence tomography study. Ophthalmology 108(4):765-772, 2001.
10. Ciardella, A.P., Klancnik, J., Schiff, W., et al. Intravitreal triamcinolone for the treatment of refractory diabetic macular edema with hard exudates: An optical coherence tomography study. Br. J. Ophthalmol. 88(9): 1131-1136, 2004.
11. Ozkiris, A., and Erkilic, K. Complications of intravitreal triamcinolone acetonide. Can. J. Ophthalmol. 40(1): 63-68, 2005.
12. Jaissle, G.B., Szurman, P., and Bartz-Schmidt, K.U. Ocular side-effects and complications of intravitreal triamcinolone acetonide injection. Ophthalmologe 101(2): 121-128, 2004.
13. Moshfeghi, D.M., Kaiser, P.K., Scott, I.U., et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am. J. Ophthalmol. 136(5):791-796, 2003.
14. Challa, J.K., Gillies, M.C., Penfold, P.L., et al. Exudative macular degeneration and intravitreal triamcinolone: 18-month follow-up. Aust. N. Z. J. Ophthalmol. 26:277-281, 1998.
15. Ober, M.D., Barile, G.R., Tari, S.R., et al. Measurement of the actual dose of triamcinolone acetonide delivered by common techniques of intravitreal injection. Am. J. Ophthalmol. 142(4):597-600, 2006.
16. Dwinger, M.C., Pieper-Bodeewes, I., Eter, N., et al. Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection. Klin. Monatsbl. Augenheilkd 222(8):638-642, 2005.
17. Gillies, M.C., Simpson, J.M., Billson, F.A., et al. Safety of an intravitreal injection of triamcinolone: Results from a randomized, clinical trial. Arch. Ophthalmol. 122(3):336-340, 2004.
18. Gillies, M.C., Kuzniarz, M., Craig, J., et al. Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior sub-capsular cataract. Ophthalmology 112(1):139-143, 2005.
19. Konstantopoulos, A., Williams, C.P., Newsom, R.S., et al. Ocular morbidity associated with intravitreal triamcinolone acetonide. Eye Epub ahead of print, 2006.
20. Moshfeghi, A.A., Scott, I.U., Flynn, H.W., Jr., et al. Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. Am. J. Ophthalmol. 138(3):489-492, 2004.
21. Brooks, H.L., Jr., Caballero, S., Jr., Newell, C.K., et al. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch. Ophthalmol. 122(12):1801-1807, 2004.
22. Wilson, C.A., Berkowitz, B.A., Sato, Y., et al. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch. Ophthalmol. 110(8):1155-1159, 1992.
23. Jonas, J.B., Kreissig, I., and Degenring, R.F. Cataract surgery after intravitreal injection of triamcinolone acetonide. Eye 18(4):361-364, 2004.
24. Jonas, J.B., Degenring, R.F., Kreissig, I., et al. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 112(4):593-598, 2005.
25. Jonas, J.B., Kreissig, I., and Degenring, R. Intraocular pressure after intravitreal injection of traimcinolone acetonide. Br. J. Ophthalmol. 87(1):24-27, 2003.
26. Rhee, D.J., Peck, R.E., Belmont, J., et al. Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br. J. Ophthalmol. Epub ahead of print, 2006.